{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T07:06:20Z","timestamp":1778310380315,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T00:00:00Z","timestamp":1713571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T00:00:00Z","timestamp":1713571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00280-024-04669-1","type":"journal-article","created":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T09:02:11Z","timestamp":1713603731000},"page":"467-473","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Preventive effect of free radical scavenger edaravone lotion on cyclophosphamide chemotherapy-induced alopecia"],"prefix":"10.1007","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9931-1866","authenticated-orcid":false,"given":"Takumi","family":"Tsuji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6363-1535","authenticated-orcid":false,"given":"Katsuaki","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Igawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Minamino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nodoka","family":"Otani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7410-6359","authenticated-orcid":false,"given":"Yuya","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2320-7958","authenticated-orcid":false,"given":"Takeyuki","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,20]]},"reference":[{"key":"4669_CR1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/pon.1245","volume":"17","author":"J Lemieux","year":"2008","unstructured":"Lemieux J, Maunsell E, Provencher L (2008) Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review. Psychooncology 17:317\u2013328. https:\/\/doi.org\/10.1002\/pon.1245","journal-title":"Psychooncology"},{"key":"4669_CR2","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00520-003-0562-5","volume":"12","author":"PJ Hesketh","year":"2004","unstructured":"Hesketh PJ, Batchelor D, Golant M, Lyman GH, Rhodes N, Yardley D (2004) Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches. Support Care Cancer 12:543\u2013549. https:\/\/doi.org\/10.1007\/s00520-003-0562-5","journal-title":"Support Care Cancer"},{"key":"4669_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1523-5394.2001.96007.pp.x","volume":"9","author":"EL McGarvey","year":"2001","unstructured":"McGarvey EL, Baum LD, Pinkerton RC, Rogers LM (2001) Psychological sequelae and alopecia among women with cancer. Cancer Pract 9:283\u2013289. https:\/\/doi.org\/10.1111\/j.1523-5394.2001.96007.pp.x","journal-title":"Cancer Pract"},{"key":"4669_CR4","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1200\/JCO.1990.8.9.1483","volume":"8","author":"B Fisher","year":"1990","unstructured":"Fisher B, Brown AM, Dimitrov V, Poisson R, Redmond C, Margolese RG, Bowman D, Wolmark N, Wickerham DL, Kardinal CG (1990) Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical adjuvant breast and Bowel Project B-15. J Clin Oncol 8:1483\u20131496. https:\/\/doi.org\/10.1200\/JCO.1990.8.9.1483","journal-title":"J Clin Oncol"},{"key":"4669_CR5","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/jnci\/djn151","volume":"100","author":"M Mart\u00edn","year":"2008","unstructured":"Mart\u00edn M, Rodr\u00edguez-Lescure \u00c1, Ruiz A, Alba E, Calvo L, Ruiz-Borrego M, Mun\u00e1rriz B, Rodr\u00edguez CA, Crespo C, de Alava E, L\u00f3pez Garc\u00eda-Asenjo JA, Guit\u00e1n MD, Almenar S, Gonz\u00e1lez-Palacios JF, Vera F, Palacios J, Ramos M, Marco JMG, Lluch A, Alvarez I, Segu\u00ed MA, Mayordomo JI, Ant\u00f3n A, Baena JM, Plazaola A, Modolell A, Pelegr\u00ed, Mel JR, Aranda E, Adrover E, \u00c1lvarez JV, Garc\u00eda Puche JL, S\u00e1nchez-Rovira P, Gonzalez S, L\u00f3pez-Vega JM, On behalf of the GEICAM 9906 Study Investigators (2008) Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer. J Natl Cancer Inst 100:805\u2013814. https:\/\/doi.org\/10.1093\/jnci\/djn151","journal-title":"J Natl Cancer Inst"},{"key":"4669_CR6","doi-asserted-by":"publisher","first-page":"e0208118","DOI":"10.1371\/journal.pone.0208118","volume":"14","author":"T Watanabe","year":"2019","unstructured":"Watanabe T, Yagata H, Saito M, Okada H, Yajima T, Tamai N, Yoshida Y, Takayama T, Imai H, Nozawa K, Sangai T, Yoshimura A, Hasegawa Y, Yamaguchi T, Shimozuma K, Ohashi Y (2019) A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients. PLoS ONE 14:e0208118. https:\/\/doi.org\/10.1371\/journal.pone.0208118","journal-title":"PLoS ONE"},{"key":"4669_CR7","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1056\/nejm197012242832621","volume":"283","author":"RO Brien","year":"1970","unstructured":"Brien RO, Zelson JH, Schwartz AD, Pearson HA (1970) Scalp tourniquet to lessen alopecia after vincristine. N Engl J Med 283:1469. https:\/\/doi.org\/10.1056\/nejm197012242832621","journal-title":"N Engl J Med"},{"key":"4669_CR8","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1001\/jama.2016.20939","volume":"317","author":"J Nangia","year":"2016","unstructured":"Nangia J, Wang T, Osborne C, Niravath P, Otte K, Papish S, Holmes F, Abraham J, Lacouture M, Courtright J, Paxman R, Rude M, Hilsenbeck S, Osborne CK, Rimawi M (2016) Effect of a scalp cooling device on alopecia in women undergoing chemotherapy for breast cancer: the SCALP randomized clinical trial. JAMA 317:596\u2013605. https:\/\/doi.org\/10.1001\/jama.2016.20939","journal-title":"JAMA"},{"key":"4669_CR9","unstructured":"FDA NEWS RELEASE (2017) FDA clears expanded use of cooling cap to reduce hair loss during chemotherapy. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-clears-expanded-use-cooling-cap-reduce-hair-loss-during-chemotherapy"},{"key":"4669_CR10","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.abd.2020.03.005","volume":"95","author":"G de Barros Silva","year":"2020","unstructured":"de Barros Silva G, Ciccolini K, Donati A, van den Hurk C (2020) Scalp cooling to prevent chemotherapy-induced alopecia. Bras Dermatol 95:631\u2013637. https:\/\/doi.org\/10.1016\/j.abd.2020.03.005","journal-title":"Bras Dermatol"},{"key":"4669_CR11","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1634\/theoncologist.2012-0332","volume":"18","author":"MMC Komen","year":"2013","unstructured":"Komen MMC, Smorenburg CH, Hurk CJG, Nortier JWR (2013) Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia. Oncologist 18:885\u2013891. https:\/\/doi.org\/10.1634\/theoncologist.2012-0332","journal-title":"Oncologist"},{"key":"4669_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jsps.2017.12.013","volume":"26","author":"S Kanchanlata","year":"2018","unstructured":"Kanchanlata S, Mustansir B, Yasar AK, Ganapathi B, Thankamani M (2018) Antioxidants as precision weapons in war against cancer chemotherapy induced toxicity - exploring the armoury of obscurity. Saudi Pharm J 26:177\u2013190. https:\/\/doi.org\/10.1016\/j.jsps.2017.12.013","journal-title":"Saudi Pharm J"},{"key":"4669_CR13","first-page":"22","volume":"13","author":"IICB Simone","year":"2007","unstructured":"Simone IICB, Simone NL, Simone V, Simone CB (2007) Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, part 1. Altern Ther Health Med 13:22\u201328","journal-title":"Altern Ther Health Med"},{"key":"4669_CR14","first-page":"40","volume":"13","author":"IICB Simone","year":"2007","unstructured":"Simone IICB, Simone NL, Simone V, Simone CB (2007) Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, part 2. Altern Ther Health Med 13:40\u201347","journal-title":"Altern Ther Health Med"},{"key":"4669_CR15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.0022-202X.2005.23787.x","volume":"125","author":"S Hendrix","year":"2005","unstructured":"Hendrix S, Handjiski B, Peters MJ, Paus R (2005) A guide to assessing damage response pathways of the hair follicle: lessons from cyclophosphamide-induced alopecia in mice. J Invest Dermatol 125:42\u201351. https:\/\/doi.org\/10.1111\/j.0022-202X.2005.23787.x","journal-title":"J Invest Dermatol"},{"key":"4669_CR16","doi-asserted-by":"publisher","first-page":"6127","DOI":"10.1007\/s00520-021-06189-7","volume":"29","author":"K Yoneda","year":"2021","unstructured":"Yoneda K, Fujii M, Imaoka A, Kobayashi R, Hayashi R, Yoshida Y, Kohno T, Tsuji T (2021) Preventive effect of edaravone ointment on cyclophosphamide-chemotherapy induced alopecia. Support Care Cancer 29:6127\u20136134. https:\/\/doi.org\/10.1007\/s00520-021-06189-7","journal-title":"Support Care Cancer"},{"key":"4669_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pathophys.2017.12.001","volume":"25","author":"AY Onaolapo","year":"2018","unstructured":"Onaolapo AY, Adebayo AA, Onaolapo OJ (2018) Oral phenytoin protects against experimental cyclophosphamide-chemotherapy induced hair loss. Pathophysiology 25:31\u201339. https:\/\/doi.org\/10.1016\/j.pathophys.2017.12.001","journal-title":"Pathophysiology"},{"key":"4669_CR18","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1111\/j.1476-5381.2009.00551.x","volume":"159","author":"J Zhao","year":"2010","unstructured":"Zhao J, Li J, Li W, Li Y, Shan H, Gong Y, Yang B (2010) Effects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing. Br J Pharmacol 159:1584\u20131594. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00551.x","journal-title":"Br J Pharmacol"},{"key":"4669_CR19","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/1523-1747.ep12382494","volume":"102","author":"MP Philpott","year":"1994","unstructured":"Philpott MP, Sanders DA, Kealey T (1994) Effects of insulin and insulin-like growth factors on cultured human hair follicles: IGF-I at physiologic concentrations is an important regulator of hair follicle growth in vitro. J Invest Dermatol 102:857\u2013861. https:\/\/doi.org\/10.1111\/1523-1747.ep12382494","journal-title":"J Invest Dermatol"},{"key":"4669_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/ijc.28961","volume":"136","author":"CM Soref","year":"2015","unstructured":"Soref CM, Fahl WE (2015) A new strategy to prevent chemotherapy and radiotherapy-induced alopecia using topically applied vasoconstrictor. Int J Cancer 136:195\u2013203. https:\/\/doi.org\/10.1002\/ijc.28961","journal-title":"Int J Cancer"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-024-04669-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-024-04669-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-024-04669-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T19:02:14Z","timestamp":1727118134000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-024-04669-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,20]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["4669"],"URL":"https:\/\/doi.org\/10.1007\/s00280-024-04669-1","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,20]]},"assertion":[{"value":"5 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the regulations for animal experiments at Setsunan University (approval Nos. K20-19 and K21-20).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}